Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Primary Pulmonary Hypertension (US)(?)

Council Members in this Study Group: 103

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Ray Coakley, MD, PHD
Ass. Professor in Medicine
University of North Carolina at Chapel Hill School of Medicine - CC

Ray Coakley, MD PhD, is a physician scientist / pulmonary & critical care specialist at the University of North Carolina, Chapel Hill. His clinical and research focus is on COPD, cystic fibrosis, lung transplantation and PAH. Specific research expertise includes airway epithelial ion/fluid transport...

Robert Aris, MD, Associate Professor of Medicine, University of North Carolina Chapel Hill - CCRobert Aris, MD
Associate Professor of Medicine
University of North Carolina Chapel Hill - CC

Robert Aris, MD, is an Associate Professor of Medicine at the University of North Carolina Chapel Hill. He is the Director of the Pulmonary Hypertension Program, the Lung Transplant Research Program and Inpatient Pulmonary Services. Dr. Aris has expertise in advanced lung diseases including cystic...

Warren Botnick, MD
President
PSS Clinical Research

Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia, since March 2003. He is Director of Critical Care Unit and Chief of Medicine at DeKalb Medical Center, Medical Director of Southern Sleep Technologies, and Co-Director of two sleep disorders centers...

Robyn Barst, MD, Director, New York- Presbyterian/Columbia University Medical CenterRobyn Barst, MD
FormerDirector
New York- Presbyterian/Columbia University Medical Center

Robyn J Barst, MD is Professor Emeritus of Pediatrics (in Medicine) at the College of Physicians and Surgeons at Columbia University. She was Director of the New York-Presbyterian Pulmonary Hypertension Center 1982-2008. She is a Fellow of the American Academy of Pediatrics, American College of Cardiology,...

Victor Tapson, MD, Medical Director of Pulmonary Hypertension Center, Duke UniversityVictor Tapson, MD
Medical Director of Pulmonary Hypertension Center
Duke University

Victor Tapson, MD, is Professor of Medicine in the Division of Pulmonary and Critical Care at Duke University School of Medicine and the Medical Director of the Duke Pulmonary Hypertension Center. Dr. Tapson was Director for the Duke Lung Transplant Program for over 10 years and Director for the Center...

Kamal Mubarak, MD
Assistant Professor & Director
University of Florida

Kamal Mubarak, MD, is an Assistant Professor and Director of the Pulmonary Vascular Disease Program at University of Florida, Gainesville. Dr. Mubarak's clinical specialties include Internal Medicine, Critical Care Medicine, and Pulmonary Disease. He is involved in numerous clinical trials in treating...

Inder Anand, MD, FACC, FRCP, DPhil, Director of the Heart Failure Program, Minneapolis VA Medical CenterInder Anand, MD, FACC, FRCP, DPhil
Director of the Heart Failure Program
Minneapolis VA Medical Center

Inder Anand, MD, FACC, FRCP, DPhil, is Professor of Medicine at the University of Minnesota. Dr. Anand is also Director of the Heart Failure Program at the Minneapolis VA Medical Center. Dr. Anand has expertise in pathophysiology and management of heart failure. He has been a principal investigator...

Glenn Rosen, MD
Associate Professor of Medicine
Stanford University Medical Center Auxiliary

Glenn Rosen, MD, is Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Stanford University with a joint appointment in Cancer Biology. Dr. Rosen has expertise in a wide variety of pulmonary diseases including lung cancer and pulmonary fibrosis. His basic research...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Heart Assisting Devices: more is not always better. | 12-02-2008
Author: GLG Expert Contributor

VAD (ventricular-assisting devices) are definitely loosing popularity. The one of main reasons for that is extremely poor reimbursement. It is hard to make conclusions from the cited study. It is performed by Medicare. The average age of patients in the study was 63 years. Age over 65 is one of contraindications...

Plavix and Nexium: incomplete data wrongly interpreted. | 11-19-2008
Analysis of: Plavix Study Faults Mixing Pills | online.wsj.com
Author: GLG Expert Contributor

Heartburn and heart attack are two types of discomfort in the chest. Patients with coronary artery disease AND gastro-esophageal reflux disease often take PPI for chest pain and, therefore, tend to seek medical attention in more advanced stages of coronary artery disease.

Oral Treprostinil: An effective medicine hiding in a study with a challenging design? | 11-18-2008
Author: Robert Aris, MD, Associate Professor of Medicine, University of North Carolina Chapel Hill - CC

This phase III study was done without the benefit of conventional drug development with Phase I and Phase II studies (which would have provided more information about the effective dose) preceding it because pharmacokinetic date from IV and SC dosing studies were used to extrapolate for the...

Stent Oligopoly: bigger stakes, bigger trials. | 10-20-2008
Author: GLG Expert Contributor

This collaboration will be very successful: the trial involving 20 000 patients will take a long time to complete. During the trial utilization of stents will not change. Upon completion of the trial it will become even more obvious that 2 years of "blood thinning" is better than 1 year for stents potency...

Amiodarone is here to stay. | 10-20-2008
Analysis of: Wyeth Heart Drug Not A Short-Term Option | www.pharmalot.com
Author: GLG Expert Contributor

Amiodarone is still one of the best drugs for atrial fibrillation despite "rare incidence" of cirrhosis, lung fibrosis and now "rare muscle injury".

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Director
  • Owner
  • President

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387